Want to join the conversation?
Clinical laboratory networks operator $LH reported 3Q15 diluted earnings of $1.49 per share, which decreased 6.3% from the same period a year ago. Net earnings improved 11.4% from last year. Adjusted EPS (excluding amortization, restructuring and special items) grew 15% to $2.07 in the quarter.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)